VEGF gradients, receptor activation, and sprout guidance in resting and exercising skeletal muscle.
Extensive experimental studies have identified vascular endothelial growth factor (VEGF) concentrations and concentration gradients as major factors in angiogenesis; however, localized in vivo measurements of these parameters have not been possible. We developed a three-dimensional computational model of skeletal muscle fibers, blood vessels, and interstitial space. Here it is applied to rat extensor digitorum longus. VEGF isoforms are secreted by myocytes, diffuse through extracellular matrix and basement membranes, and bind endothelial cell surface receptors on blood vessels. In addition, one isoform, VEGF164, binds to proteoglycans in the interstitial space. VEGF secretion rate is determined from the predicted tissue oxygen level through its effect on the hypoxia inducible factor-1alpha transcription factor. We estimate VEGF secretion and its concentrations and gradients in resting muscle and for different levels of exercise. The effects of low levels of inspired oxygen are also studied. We predict that the high spatial heterogeneity of muscle fiber VEGF secretion in hypoxic tissue leads to significant gradients of VEGF concentration and VEGF receptor activation. VEGF concentration gradients are predicted to be significant in both resting and exercising muscle (4% and 6-8% change in VEGF over 10 microm, respectively), sufficient for chemotactic guidance of 50-microm-long sprout tip cells. VEGF gradients also result in heterogeneity in VEGF receptor activation--a possible explanation for the stochasticity of sprout location. In the absence of interstitial flow, gradients are 10-fold steeper in the transverse direction (i.e., perpendicular to the muscle fibers) than in the longitudinal direction. This may explain observed perpendicular anastomoses in skeletal muscle.
Mac Gabhann
Feilim
F
Dept. of Biomedical Engineering, Johns Hopkins Univ. School of Medicine, 720 Rutland Ave., Baltimore, MD 2120, USA. feilim@jhu.edu
Ji
James W
JW
Popel
Aleksander S
AS
D000818:Animals; D001692:Biological Transport / Q000502:physiology; D002455:Cell Division / Q000502:physiology; D042783:Endothelial Cells / Q000166:cytology / Q000502:physiology; D019812:Heparan Sulfate Proteoglycans / Q000378:metabolism; D008962:Models, Theoretical; D018482:Muscle, Skeletal / Q000098:blood supply* / Q000502:physiology; D018919:Neovascularization, Physiologic / Q000502:physiology*; D010100:Oxygen / Q000378:metabolism; D010805:Physical Conditioning, Animal / Q000502:physiology*; D051381:Rats; D040262:Receptors, Vascular Endothelial Growth Factor / Q000378:metabolism*; D012146:Rest / Q000502:physiology*; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism*
D019812:Heparan Sulfate Proteoglycans; D042461:Vascular Endothelial Growth Factor A; D040262:Receptors, Vascular Endothelial Growth Factor; D010100:Oxygen